Literature DB >> 18471449

Effect of exercise training in supervised cardiac rehabilitation programs on prognostic variables from the exercise tolerance test.

Brian J Adams1, John G Carr, Al Ozonoff, Michael S Lauer, Gary J Balady.   

Abstract

Meta-analyses showed that exercise training decreased mortality in patients after myocardial infarction, but no single adequately powered trial has shown this benefit. The purpose of this study was to evaluate the effect of cardiac rehabilitative exercise training on prognostic variables derived from the exercise tolerance test and whether these changes had an effect on predicted cardiovascular and all-cause mortality using externally validated risk scores. Two hundred ten consecutive patients who completed a 12-week cardiac rehabilitation program were analyzed. Peak MET level, heart rate recovery, chronotropic index, Duke prognostic score, and Cleveland Clinic Foundation risk score obtained at program entry and exit were compared. All prognostic variables and risk score-derived predicted 5-year mortality rates improved significantly after cardiac rehabilitation. Exercise capacity increased by 32% (6.6 +/- 2.7 to 8.7 +/- 2.9 METS; p <0.0001), heart rate recovery increased by 20% (15 +/- 9 to 18 +/- 10 beats/min; p <0.0001), and chronotropic index increased by 11% (56 +/- 22% to 62 +/- 22%; p <0.0001). Duke prognostic score 5-year predicted cardiovascular mortality rate decreased by 33% (6 +/- 4% to 4 +/- 2%; p <0.0001), and Cleveland Clinic Foundation risk score 5-year predicted total mortality rate decreased by 40% (5 +/- 7% to 3 +/- 5%; p <0.0001). These improvements remained significant in high-risk subgroups. When controlled for age, gender, diabetes, MET level achieved, ejection fraction, and beta-blocker use, changes remained significant (p <0.0001) for each outcome measure. In conclusion, exercise training in supervised cardiac rehabilitation programs significantly improved exercise capacity, measures of chronotropic dynamics, and prognostic risk scores. These differences translate into a decrease in predicted mortality.

Entities:  

Mesh:

Year:  2008        PMID: 18471449     DOI: 10.1016/j.amjcard.2008.01.016

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  6 in total

Review 1.  Chronotropic Incompetence During Exercise in Type 2 Diabetes: Aetiology, Assessment Methodology, Prognostic Impact and Therapy.

Authors:  Charly Keytsman; Paul Dendale; Dominique Hansen
Journal:  Sports Med       Date:  2015-07       Impact factor: 11.136

2.  Heart Rate Recovery as a Novel Test for Predicting Cardiac Involvement in Beta-Thalassemia Major.

Authors:  Selcuk Kucukseymen; Isa Oner Yuksel; Goksel Cagirci; Erkan Koklu; Volkan Karakus; Serkan Cay; Gorkem Kus; Erdal Kurtoglu; Sakir Arslan
Journal:  Acta Cardiol Sin       Date:  2017-07       Impact factor: 2.672

3.  Physiological and exercise capacity improvements in women completing cardiac rehabilitation.

Authors:  Theresa M Beckie; Jason W Beckstead; Kevin Kip; Gerald Fletcher
Journal:  J Cardiopulm Rehabil Prev       Date:  2013 Jan-Feb       Impact factor: 2.081

4.  Improvements in heart rate recovery among women after cardiac rehabilitation completion.

Authors:  Theresa M Beckie; Jason W Beckstead; Kevin E Kip; Gerald Fletcher
Journal:  J Cardiovasc Nurs       Date:  2014 Jan-Feb       Impact factor: 2.083

5.  Estimation of Heart Rate Recovery after StairClimbing Using aWrist-Worn Device.

Authors:  Daivaras Sokas; Andrius Petrėnas; Saulius Daukantas; Andrius Rapalis; Birutė Paliakaitė; Vaidotas Marozas
Journal:  Sensors (Basel)       Date:  2019-05-07       Impact factor: 3.576

6.  Brief Vigorous Stair Climbing Effectively Improves Cardiorespiratory Fitness in Patients With Coronary Artery Disease: A Randomized Trial.

Authors:  Emily C Dunford; Sydney E Valentino; Jonathan Dubberley; Sara Y Oikawa; Chris McGlory; Eva Lonn; Mary E Jung; Martin J Gibala; Stuart M Phillips; Maureen J MacDonald
Journal:  Front Sports Act Living       Date:  2021-02-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.